Skip to main content
SanofiRevenue

Sanofi Consumer Healthcare India Reports Strong Q1'26 Performance with 33% Revenue Growth

What happened

Sanofi Consumer Healthcare India's revenue for Q4FY26 grew 35.29% year-over-year to ₹2,348 million.

Source

Article excerpt

Highlighted: the sentence this signal was extracted from

Sanofi Consumer Healthcare India delivered robust Q4FY26 performance with net profit surging 35.60% to ₹678 million and revenue growing 35.29% to ₹2,348 million. The company successfully relaunched previously recalled products and published its financial results in newspapers following SEBI compliance requirements. *this image is generated using AI for illustrative purposes only. Sanofi Consumer Healthcare India Limited has announced its unaudited financial results for the quarter ended March 31, 2026, demonstrating strong operational performance across key metrics. The Board of Directors approved the results during a meeting held on April 28, 2026, from 1:00 p.m. to 3:40 p.m. The company has submitted the required financial documentation to both BSE Limited and National Stock Exchange of India Limited, complying with SEBI Listing Regulations. The company delivered impressive financial results for Q4FY26, with net profit reaching ₹678 million compared to ₹500 million in the corresponding quarter of the previous year, representing a 35.60% year-over-year growth. Revenue grew to ₹2,348 million from ₹1,778 million, reflecting strong business momentum of 35.29% growth. Basic and diluted earnings per share (Rs. 10/- each) stood at ₹29.44 for Q4FY26, compared to ₹21.69 in the same quarter of the previous year. Total income from operations for the quarter ended March 31, 2026 was...

Keep reading with a free account

The rest of this article, and every signal for Sanofi, is in your free account.

Extracted by Autobound

From the Signal API record
Event
Revenue

What this signalsRevenue results often set the next budget cycle.

Takes effect
Mar 31, 2026

More revenue signals at other companies

The full record

From the Signal API record

Extraction

Confidence
95%
Detected
Aug 30, 2026
signal_type
news
signal_subtype
has_revenue

Use this data

Get every revenue signal for Sanofi and the companies you sell to, in the tools you already use.

  1. Ask Claude about it

    Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Sanofi this week?”

  2. Send it to your own tools

    The Signal API returns revenue signals for any list of companies as JSON, for your CRM, warehouse or app.

  3. Try it free

    Sign up and spend your free credits on the companies you sell to.

    Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full news record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

  • linkedin_urlValue in the API
  • industriesValue in the API
  • employee_count_lowValue in the API
  • employee_count_highValue in the API
  • revenueValue in the API
  • descriptionValue in the API

Signal

  • signal_nameValue in the API
  • associationValue in the API
Show the full JSONThe record on this page and the API request

GET /v1/signals/7552f692-6154-c677-48dc-1e9c09bab8b0 returns this record as JSON. POST /v1/companies/enrich returns every signal for sanofi.com.

{
  "signal_id": "7552f692-6154-c677-48dc-1e9c09bab8b0",
  "signal_type": "news",
  "signal_subtype": "has_revenue",
  "detected_at": "2026-08-30T09:03:09+00:00",
  "company": {
    "name": "Sanofi",
    "domain": "sanofi.com"
  },
  "data": {
    "url": "https://scanx.trade/stock-market-news/companies/sanofi-consumer-healthcare-india-reports-strong-q1-26-performance-with-33-revenue-growth/39082561",
    "title": "Sanofi Consumer Healthcare India Reports Strong Q1'26 Performance with 33% Revenue Growth - scanx.trade",
    "excerpt": "Sanofi Consumer Healthcare India delivered robust Q4FY26 performance with net profit surging 35.60% to ₹678 million and revenue growing 35.29% to ₹2,348 million. The company successfully relaunched previously recalled products and published its financial results in newspapers following SEBI compliance requirements. *this image is generated using AI for illustrative purposes only. Sanofi Consumer Healthcare India Limited has announced its unaudited financial results for the quarter ended March 31, 2026, demonstrating strong operational performance across key metrics. The Board of Directors approved the results during a meeting held on April 28, 2026, from 1:00 p.m. to 3:40 p.m. The company has submitted the required financial documentation to both BSE Limited and National Stock Exchange of India Limited, complying with SEBI Listing Regulations. The company delivered impressive financial results for Q4FY26, with net profit reaching ₹678 million compared to ₹500 million in the corresponding quarter of the previous year, representing a 35.60% year-over-year growth. Revenue grew to ₹2,348 million from ₹1,778 million, reflecting strong business momentum of 35.29% growth. Basic and diluted earnings per share (Rs. 10/- each) stood at ₹29.44 for Q4FY26, compared to ₹21.69 in the same quarter of the previous year. Total income from operations for the quarter ended March 31, 2026 was...",
    "summary": "Sanofi Consumer Healthcare India's revenue for Q4FY26 grew 35.29% year-over-year to ₹2,348 million.",
    "planning": false,
    "image_url": "https://news-images.dhan.co/sanofi-consumer-healthcare-india-reports-strong-q1-26-performance-with-33-revenue-growth.jpg",
    "confidence": 0.95,
    "published_at": "2026-08-30T09:03:09Z",
    "effective_date": "2026-03-31",
    "article_sentence": "Revenue grew to ₹2,348 million from ₹1,778 million, reflecting strong business momentum of 35.29% growth."
  }
}

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.